(S)-2-((tert-Butoxycarbonyl)amino)-2-cyclobutylacetic acid

Catalog No. :
ACPXDV640
CAS No. :
155905-77-4
Molecular Formula :
C11H19NO4
Molecular Weight :
229.28

IUPAC Name:(S)-2-((tert-butoxycarbonyl)amino)-2-cyclobutylacetic acid

(S)-2-((tert-Butoxycarbonyl)amino)-2-cyclobutylacetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$184.00Login to see priceIn stockIn stock
5g98%$669.00Login to see priceIn stockIn stock
25g98%$2935.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-((tert-Butoxycarbonyl)amino)-2-cyclobutylacetic acid
IUPAC Name(S)-2-((tert-butoxycarbonyl)amino)-2-cyclobutylacetic acid
MDL No.MFCD06659975
Molecular FormulaC11H19NO4
Molecular Weight229.28
SMILESO=C(O)[C@@H](NC(OC(C)(C)C)=O)C1CCC1
InChI KeyOHDFGIXTRBDGRB-QMMMGPOBSA-N
Synonym155905-77-4 | Boc-L-cyclobutylglycine | (S)-2-((tert-Butoxycarbonyl)amino)-2-cyclobutylacetic acid | (2S)-2-cyclobutyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid | MFCD06659975 | SCHEMBL1294357 | (S)-2-((tert-Butoxycarbonyl)amino)-2-cyclobutylaceticacid | (S)
CAS No.155905-77-4
PubChem CID34178694

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPXDV640 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQSZP721 route compound structure diagram
    ACQSZP72149607-08-1 In Stock
  4. Then
  5. ACPXDV640 route product structure diagram
    ACPXDV640155905-77-4 In Stock
Inquiry

2. ACPXDV640 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPXDV640 route product structure diagram
    ACPXDV640155905-77-4 In Stock
Inquiry

Comments (0)